The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Epperly Melissa B, since 2020.
This trader's CIK number is 1807359.
At the time of last reporting, Epperly Melissa B, was the Chief Financial Officer of Zentalis Pharmaceuticals, Inc.. (stock ticker symbol ZNTL).
Also see all insider trading activities at Zentalis Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ZNTL | 0 | $0 | 11,242 | $129,475 | 0 | $0 |
| 2023 | ZNTL | 0 | $0 | 13,333 | $265,820 | 0 | $0 |
| 2022 | ZNTL | 0 | $0 | 18,993 | $960,997 | 0 | $0 |
| 2021 | ZNTL | 9,611 | $499,751 | 35,605 | $1,666,651 | 0 | $0 |
| 2020 | ZNTL | 20,000 | $360,000 | 19,850 | $1,013,881 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-02-12 | ZNTL | Sale | 2,573 | 11.44 | 29,435 |
| 2024-02-02 | ZNTL | Sale | 8,669 | 11.54 | 100,040 |
| 2023-10-04 | ZNTL | Sale | 5,482 | 19.67 | 107,819 |
| 2023-02-13 | ZNTL | Sale | 2,624 | 20.42 | 53,592 |
| 2023-02-14 | ZNTL | Sale | 5,227 | 19.98 | 104,409 |
| 2022-04-04 | ZNTL | Sale | 17,080 | 50.75 | 866,878 |
| 2022-02-23 | ZNTL | Sale | 1,913 | 49.20 | 94,119 |
| 2021-08-19 | ZNTL | Buy | 8,285 | 52.00 | 430,803 |
| 2021-08-18 | ZNTL | Buy | 1,326 | 52.00 | 68,948 |
| 2021-07-01 | ZNTL | Sale | 3,083 | 51.61 | 159,113 |
| 2021-06-01 | ZNTL | Sale | 3,083 | 54.45 | 167,857 |
| 2021-05-03 | ZNTL | Sale | 3,083 | 58.75 | 181,135 |
| 2021-04-05 | ZNTL | Sale | 17,107 | 44.02 | 753,015 |
| 2021-03-01 | ZNTL | Sale | 3,083 | 41.67 | 128,484 |
| 2021-02-01 | ZNTL | Sale | 3,083 | 37.89 | 116,827 |
| 2021-01-04 | ZNTL | Sale | 3,083 | 51.97 | 160,220 |
| 2020-12-04 | ZNTL | Sale | 7,220 | 50.97 | 367,988 |
| 2020-12-07 | ZNTL | Sale | 6,464 | 52.87 | 341,725 |
| 2020-12-02 | ZNTL | Sale | 3,083 | 51.78 | 159,628 |
| 2020-04-07 | ZNTL | Buy | 20,000 | 18.00 | 360,000 |
| 2020-11-23 | ZNTL | Sale | 3,083 | 46.88 | 144,540 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Epperly Melissa B, (Chief Financial Officer of Zentalis Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.